Pioz MF G1 Tablet SR

18% OFF
18% OFF

Original price was: ₹133.50.Current price is: ₹110.00.

Pioz MF G1 Tablet SR
Prescription Required
Marketer: USV Ltd
SALT COMPOSITION: Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

10 Tablet

Buy Now
Category:

Description

About Pioz MF G1 Tablet SR:
Pioz MF G1 Tablet SR combines Glimepiride, a sulfonylurea that promotes insulin secretion, Metformin, a biguanide that lowers hepatic glucose production, and Pioglitazone, a thiazolidinedione that enhances insulin sensitivity. This triple therapy addresses multiple mechanisms of blood sugar control in patients with type 2 diabetes mellitus who need enhanced glycemic management. The sustained-release (SR) formulation ensures convenient once-daily dosing and steady blood sugar control.

How It Works:

  • Glimepiride: Stimulates pancreatic beta cells to release insulin, lowering blood sugar.

  • Metformin: Reduces liver glucose production and increases peripheral glucose uptake.

  • Pioglitazone: Improves insulin sensitivity in muscle, fat, and liver tissues.

  • The combination provides complementary effects, controlling both fasting and postprandial blood glucose.

Uses:

  • Management of type 2 diabetes mellitus

  • Enhances insulin secretion and sensitivity

  • Controls fasting and post-meal blood sugar levels

  • Suitable for patients requiring triple oral antidiabetic therapy

Directions for Use:

  • Take once daily, preferably with meals, as prescribed by your doctor.

  • Swallow the tablet whole, do not crush or chew.

  • Maintain a balanced diet, exercise routine, and healthy lifestyle to optimize blood sugar control.

Side Effects:
Common side effects may include:

  • Hypoglycemia (low blood sugar)

  • Gastrointestinal discomfort (nausea, diarrhea)

  • Mild weight gain or edema

  • Rare: liver dysfunction or heart failure exacerbation

Seek medical attention if you experience severe dizziness, low blood sugar, swelling, or signs of liver problems.

Precautions:

  • Avoid in patients with type 1 diabetes, severe liver or kidney disease, or heart failure

  • Regular monitoring of blood sugar, liver and kidney function, and body weight is recommended

  • Not recommended during pregnancy or breastfeeding unless prescribed

  • Use caution with other antidiabetic drugs to prevent hypoglycemia

Leave a Reply

Your email address will not be published. Required fields are marked *